Wed Sep 25 04:14:05 UTC 2024: ## Novo Nordisk CEO Roasted Online After Senate Testimony on High Drug Prices
Novo Nordisk CEO Lars Fruergaard Jørgensen faced public backlash after testifying before the Senate Committee on Health, Education, Labor, and Pensions yesterday. The testimony, focusing on the high prices of the company’s weight loss and diabetes drugs, was met with widespread criticism online.
Jørgensen defended the prices, arguing that the drugs provide significant benefits to patients. However, his statement was met with skepticism, particularly in light of the company’s recent record profits. Many viewers pointed to the significant financial burden placed on patients and the lack of transparency in pricing.
The online response, dubbed a “ratio” – a term used when a social media post receives significantly more negative reactions than positive ones – was swift and severe. Numerous Twitter users expressed their outrage at the company’s pricing practices, highlighting the inaccessibility of life-saving medications to many Americans.
The incident serves as a stark reminder of the growing public concern over the cost of prescription drugs in the United States. This public outcry is likely to fuel further debate and scrutiny on pharmaceutical pricing policies.
First Piper 